EHS
EHS

New patent for Pharmacyclics Inc drug IMBRUVICA

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are twenty-four patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch – Make Better Decisions.

The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on Biotechblog.

EHS
Back to top button